StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)

Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –

Nephros free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Nephros's free cash flow for the twelve months ending Dec 31, 2024 was -$547.00K. For fiscal 2024 it was -$547.00K, down 172.7% from the year before. The highest annual figure on record is $752.00K in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$547.00K-172.7%
FY2023Dec 31, 2023$752.00K–
FY2022Dec 31, 2022-$3.37M–
FY2021Dec 31, 2021-$1.45M–
FY2020Dec 31, 2020-$7.14M–
FY2019Dec 31, 2019-$2.29M–
FY2016Dec 31, 2016-$2.16M–
FY2015Dec 31, 2015-$3.83M–
FY2013Dec 31, 2013-$3.58M–
FY2012Dec 31, 2012-$1.56M–
FY2010Dec 31, 2010-$1.32M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$1.30M–
Q3 FY2024Sep 30, 2024-$623.00K–
Q4 FY2022Dec 31, 2022-$195.00K–
Q3 FY2022Sep 30, 2022-$170.00K–
Q2 FY2022Jun 30, 2022-$1.18M–
Q1 FY2022Mar 31, 2022-$1.83M–
Q4 FY2021Dec 31, 2021-$335.00K–
Q3 FY2021Sep 30, 2021-$923.00K–
Q2 FY2021Jun 30, 2021-$117.00K-132.1%
Q1 FY2021Mar 31, 2021-$78.00K–
Q4 FY2020Dec 31, 2020-$1.53M–
Q3 FY2020Sep 30, 2020-$1.83M–
Q4 FY2019Dec 31, 2019$364.00K–
Q4 FY2016Dec 31, 2016-$528.00K–
Q3 FY2016Sep 30, 2016-$795.00K–

More Nephros figures

See a number that looks wrong?